Jardiance Met 5mg/500mg Tablet
Jardiance Met 5mg/500mg Tablet
Empagliflozin (5mg) + Metformin (500mg)
Cheaper alternative availability
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
About This Medicine
Product description & overview
Jardiance Met 5mg/500mg Tablets: For Managing Type 2 Diabetes
Jardiance Met 5mg/500mg tablets combine the efficacy of two diabetes medications: empagliflozin (5mg) and metformin (500mg). This combination offers a unique approach to managing blood glucose levels in adults with type 2 diabetes.
Empagliflozin: A sodium-glucose cotransporter-2 (SGLT2) inhibitor, empagliflozin works by reducing the amount of sugar your kidneys reabsorb back into the bloodstream. This helps lower blood sugar levels and reduce the risk of diabetic complications.
Metformin: A first-line medication for type 2 diabetes, metformin lowers blood sugar levels by reducing glucose production in the liver and enhancing insulin sensitivity in cells.
Jardiance Met delivers a comprehensive solution for managing Type 2 diabetes. This dual-action formulation offers increased efficacy and potentially improved patient outcomes compared to monotherapy with either empagliflozin or metformin alone.
Important Note: Always consult your healthcare provider before taking any medications, especially if you have pre-existing medical conditions or are on multiple other medications.
Active composition
Metformin 500 mg
+1 more active ingredient
About Metformin
Metformin is an oral antihyperglycemic agent used to manage type 2 diabetes mellitus. It works by decreasing glucose production in the liver and improving insulin sensitivity. Metformin is effective in controlling blood sugar levels and preventing diabetes-related complications. In summary, Metformin is vital for managing type 2 diabetes.
How It Works
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
All Active Ingredients
Empagliflozin
Empagliflozin inhibits the sodium-glucose co-transporter 2 (SGLT2) in the renal proximal tubules, reducing glucose reabsorption and increasing urinary glucose excretion.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
Caution is advised when consuming alcohol with Jardiance Met 5mg/500mg Tablet. Please consult your doctor.
High Risk
Pregnancy
Jardiance Met 5mg/500mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Driving
Jardiance Met 5mg/500mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
Liver
Jardiance Met 5mg/500mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Jardiance Met 5mg/500mg Tablet may be needed. Please consult your doctor.
Regular Checkup
Breastfeeding
Jardiance Met 5mg/500mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Kidney
Jardiance Met 5mg/500mg Tablet is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Jardiance Met 5mg/500mg Tablet